There are several factors that can contribute to the development of hypertension, including genetics, age, obesity, lack of physical activity, excessive salt intake, and chronic conditions such as diabetes and kidney disease
[11] In April 2026 the sponsor announced that SYNCHRONIZE-1 a double-blind, placebo-controlled study of roughly 725 adults with obesity or overweight without diabetes met its co-primary endpoints, reporting mean bodyweight loss of about 16.6% at 76 weeks versus about 3.2% on placebo, with a large proportion of participants achieving at least 5% weight loss
207 In these cases, patients had chronic and often daily headache, additional diverse symptoms (e.g
Start Your Weight Loss Treatment Today If your interest in Ozempic for weight loss brought you here, you now know of more suitable alternatives